Literature DB >> 19664364

TDP-43 and frontotemporal dementia.

William T Hu1, Murray Grossman.   

Abstract

TAR DNA-binding protein of about 43 kDa (TDP-43) is the main ubiquitinated peptide in tau-negative frontotemporal lobar degeneration (FTLD). TDP-43 is typically a nuclear protein, and its aggregation and cytoplasmic translocation are thought to represent major steps in the pathogenesis of FTLD due to TDP-43 proteinopathy (FTLD-TDP). Certain clinical syndromes of frontotemporal dementia are preferentially associated with pathologic findings of FTLD-TDP, and TDP-43 pathology represents the connection between FTLD-TDP and amyotrophic lateral sclerosis. Recent advances in clinical, genetic, and pathologic studies of FTLD-TDP and amyotrophic lateral sclerosis have shed light on the potentially pathogenic role of TDP-43 and identified TDP-43 itself as a candidate biomarker for antemortem diagnosis of FTLD-TDP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664364     DOI: 10.1007/s11910-009-0052-3

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  54 in total

1.  Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.

Authors:  Keith A Josephs; Zeshan Ahmed; Omi Katsuse; Joseph F Parisi; Bradley F Boeve; David S Knopman; Ronald C Petersen; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Ryan J Uitti; Rosa Rademakers; Jennifer Adamson; Matthew Baker; Michael L Hutton; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2007-02       Impact factor: 3.685

2.  Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations.

Authors:  Mark S Forman; Ian R Mackenzie; Nigel J Cairns; Eric Swanson; Philip J Boyer; David A Drachman; Bharati S Jhaveri; Jason H Karlawish; Alan Pestronk; Thomas W Smith; Pang-Hsien Tu; Giles D J Watts; William R Markesbery; Charles D Smith; Virginia E Kimonis
Journal:  J Neuropathol Exp Neurol       Date:  2006-06       Impact factor: 3.685

3.  CSF biomarkers in frontotemporal lobar degeneration with known pathology.

Authors:  H Bian; J C Van Swieten; S Leight; L Massimo; E Wood; M Forman; P Moore; I de Koning; C M Clark; S Rosso; J Trojanowski; V M-Y Lee; M Grossman
Journal:  Neurology       Date:  2008-05-06       Impact factor: 9.910

4.  Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Authors:  Ian R A Mackenzie; Eileen H Bigio; Paul G Ince; Felix Geser; Manuela Neumann; Nigel J Cairns; Linda K Kwong; Mark S Forman; John Ravits; Heather Stewart; Andrew Eisen; Leo McClusky; Hans A Kretzschmar; Camelia M Monoranu; J Robin Highley; Janine Kirby; Teepu Siddique; Pamela J Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

5.  Clinical and pathological continuum of multisystem TDP-43 proteinopathies.

Authors:  Felix Geser; Maria Martinez-Lage; John Robinson; Kunihiro Uryu; Manuela Neumann; Nicholas J Brandmeir; Sharon X Xie; Linda K Kwong; Lauren Elman; Leo McCluskey; Chris M Clark; Joe Malunda; Bruce L Miller; Earl A Zimmerman; Jiang Qian; Vivianna Van Deerlin; Murray Grossman; Virginia M-Y Lee; John Q Trojanowski
Journal:  Arch Neurol       Date:  2009-02

6.  Progranulin (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival.

Authors:  Zhiheng He; Amin Ismail; Leonid Kriazhev; Gulzhakhan Sadvakassova; Andrew Bateman
Journal:  Cancer Res       Date:  2002-10-01       Impact factor: 12.701

7.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations.

Authors:  Ian R A Mackenzie; Manuela Neumann; Eileen H Bigio; Nigel J Cairns; Irina Alafuzoff; Jillian Kril; Gabor G Kovacs; Bernardino Ghetti; Glenda Halliday; Ida E Holm; Paul G Ince; Wouter Kamphorst; Tamas Revesz; Annemieke J M Rozemuller; Samir Kumar-Singh; Haruhiko Akiyama; Atik Baborie; Salvatore Spina; Dennis W Dickson; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2008-11-18       Impact factor: 17.088

8.  Clinical and pathological characterization of progressive aphasia.

Authors:  Jonathan A Knibb; John H Xuereb; Karalyn Patterson; John R Hodges
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

9.  Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

Authors:  E Buratti; T Dörk; E Zuccato; F Pagani; M Romano; F E Baralle
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

10.  TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration.

Authors:  Penelope Foulds; Erica McAuley; Linda Gibbons; Yvonne Davidson; Stuart M Pickering-Brown; David Neary; Julie S Snowden; David Allsop; David M A Mann
Journal:  Acta Neuropathol       Date:  2008-05-28       Impact factor: 17.088

View more
  6 in total

Review 1.  The neuropathology and cerebrovascular mechanisms of dementia.

Authors:  Limor Raz; Janice Knoefel; Kiran Bhaskar
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

2.  Chronic Traumatic Encephalopathy in Athletes Involved with High-impact Sports.

Authors:  Cyrus Safinia; Eric M Bershad; H Brent Clark; Karen SantaCruz; Naila Alakbarova; Jose I Suarez; Afshin A Divani
Journal:  J Vasc Interv Neurol       Date:  2016-10

Review 3.  Exosome: The "Off-the-Shelf" Cellular Nanocomponent as a Potential Pathogenic Agent, a Disease Biomarker, and Neurotherapeutics.

Authors:  Satyajit Ghosh; Surajit Ghosh
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

Review 4.  The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease.

Authors:  Dilek Inekci; Ditte Svendsen Jonesco; Sophie Kennard; Morten Asser Karsdal; Kim Henriksen
Journal:  Front Neurol       Date:  2015-05-11       Impact factor: 4.003

5.  Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants.

Authors:  Lalitha Venkataraman; Ping He; Galam Khan; Brent T Harris; Michael R Sierks
Journal:  BMC Neurosci       Date:  2020-09-04       Impact factor: 3.288

6.  Network Theoretical Approach to Explore Factors Affecting Signal Propagation and Stability in Dementia's Protein-Protein Interaction Network.

Authors:  Amit Kumar Lalwani; Kushagra Krishnan; Sali Abubaker Bagabir; Mustfa F Alkhanani; Atiah H Almalki; Shafiul Haque; Saurabh Kumar Sharma; R K Brojen Singh; Md Zubbair Malik
Journal:  Biomolecules       Date:  2022-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.